MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN

MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN was reported 1977 times

MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 148 0.4884
1 AMYLOID ARTHROPATHY 29 0.4143
2 TRANSFERRIN SATURATION ABNORMAL 5 0.2941
3 FEMALE GENITAL TRACT FISTULA 159 0.0930
4 TOTAL LUNG CAPACITY INCREASED 23 0.0846
5 CARBUNCLE 23 0.0813
6 PRODUCT ADMINISTRATION ISSUE 14 0.0670
7 RADICULOPATHY 154 0.0584
8 ANAL INFLAMMATION 37 0.0579
9 CHRONIC SINUSITIS 198 0.0527
10 PROCTITIS 147 0.0524
11 SARS-COV-2 TEST NEGATIVE 33 0.0489
12 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 23 0.0440
13 MACULAR DEGENERATION 460 0.0385
14 ASYMPTOMATIC BACTERIURIA 5 0.0368
15 MONOCLONAL IMMUNOGLOBULIN PRESENT 22 0.0289
16 ANAL EROSION 3 0.0273
17 WRIST DEFORMITY 15 0.0244
18 DERMATOPHYTOSIS 5 0.0176
19 SERUM FERRITIN ABNORMAL 5 0.0156
20 GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0154
21 HYPOTHALAMO-PITUITARY DISORDER 22 0.0151
22 NASAL FLARING 2 0.0148
23 VAGINAL DISCHARGE 148 0.0146
24 PARAESTHESIA ORAL 198 0.0137
25 MUCOSAL HYPERTROPHY 2 0.0135
26 MIGRAINE WITHOUT AURA 4 0.0133
27 NEUROBLASTOMA 5 0.0131
28 NUCLEAR MAGNETIC RESONANCE IMAGING 2 0.0120
29 ORAL CANDIDIASIS 149 0.0113
30 CREATININE RENAL CLEARANCE ABNORMAL 5 0.0108
31 PULMONARY PAIN 30 0.0103
32 GASTROSTOMY TUBE SITE COMPLICATION 2 0.0100
33 NODULAR RASH 2 0.0090
34 EPILEPTIC ENCEPHALOPATHY 2 0.0090
35 MENINGOENCEPHALITIS HERPETIC 4 0.0089
36 FEEDING INTOLERANCE 4 0.0089
37 PROCTALGIA 56 0.0087
38 DERMATITIS DIAPER 6 0.0085
39 NEUROGENIC BOWEL 2 0.0084
40 GINGIVAL ERYTHEMA 7 0.0081
41 FIBROSIS 22 0.0071
42 ALVEOLAR OSTEITIS 3 0.0071
43 JARISCH-HERXHEIMER REACTION 5 0.0070
44 BURSA DISORDER 2 0.0069
45 PROCEDURAL PAIN 190 0.0068
46 JAUNDICE CHOLESTATIC 23 0.0065
47 HYPOMANIA 23 0.0062
48 PENILE ULCERATION 2 0.0061
49 SKIN CANDIDA 3 0.0057
50 CHRONIC RESPIRATORY DISEASE 2 0.0057
51 FREQUENT BOWEL MOVEMENTS 153 0.0057
52 XEROSIS 7 0.0057
53 FAT EMBOLISM 2 0.0056
54 RHINITIS ALLERGIC 25 0.0056
55 PNEUMONIA STREPTOCOCCAL 6 0.0055
56 TINEA INFECTION 6 0.0054
57 INJECTION SITE ULCER 5 0.0053
58 LIFE EXPECTANCY SHORTENED 3 0.0053
59 NASAL POLYPS 26 0.0053
60 AORTIC CALCIFICATION 3 0.0052
61 SARCOIDOSIS 23 0.0048
62 HAEMANGIOMA OF SKIN 2 0.0046
63 FINGER DEFORMITY 22 0.0045
64 DYSLIPIDAEMIA 23 0.0045
65 LICHEN SCLEROSUS 3 0.0044
66 ECZEMA HERPETICUM 2 0.0043
67 DISSEMINATED ASPERGILLOSIS 2 0.0042
68 LANGUAGE DISORDER 9 0.0042
69 OVERWEIGHT 22 0.0041
70 LENTIGO 2 0.0040
71 COLITIS 151 0.0040
72 METASTATIC SQUAMOUS CELL CARCINOMA 2 0.0039
73 BRONCHIECTASIS 26 0.0039
74 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 3 0.0038
75 MUSCLE DISCOMFORT 3 0.0038
76 RECTAL HAEMORRHAGE 163 0.0038
77 BRONCHOPULMONARY DYSPLASIA 3 0.0037
78 GRANULOMA SKIN 3 0.0037
79 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 3 0.0036
80 MILK ALLERGY 2 0.0036
81 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
82 ENTEROVIRUS INFECTION 3 0.0035
83 COLITIS ULCERATIVE 152 0.0034
84 CANDIDA SEPSIS 3 0.0033
85 GRUNTING 2 0.0033
86 CEREBRAL ASPERGILLOSIS 2 0.0033
87 ENTEROCOCCUS TEST POSITIVE 2 0.0031
88 INFUSION RELATED REACTION 201 0.0030
89 RENAL CYST 24 0.0030
90 ACCIDENT 36 0.0030
91 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 214 0.0030
92 CARDIAC MURMUR 26 0.0030
93 KERATOACANTHOMA 2 0.0029
94 ANGULAR CHEILITIS 2 0.0029
95 KIDNEY FIBROSIS 5 0.0029
96 HAEMATOCHEZIA 159 0.0029
97 LEIOMYOMA 2 0.0029
98 PUNCTURE SITE HAEMORRHAGE 2 0.0028
99 ANTIBODY TEST ABNORMAL 2 0.0028
100 APLASTIC ANAEMIA 14 0.0027
101 DYSAESTHESIA 8 0.0026
102 DEBRIDEMENT 2 0.0026
103 PURPURA 23 0.0026
104 NEPHROPATHY 24 0.0026
105 METAPNEUMOVIRUS INFECTION 2 0.0026
106 BICYTOPENIA 5 0.0025
107 CHRONIC RESPIRATORY FAILURE 3 0.0025
108 GUTTATE PSORIASIS 2 0.0024
109 BOTULISM 2 0.0024
110 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
111 LUNG NEOPLASM 10 0.0023
112 MEAN CELL VOLUME INCREASED 6 0.0023
113 RHINOVIRUS INFECTION 9 0.0023
114 BODY HEIGHT DECREASED 24 0.0022
115 DECUBITUS ULCER 18 0.0022
116 PNEUMONIA VIRAL 7 0.0022
117 CERUMEN IMPACTION 2 0.0022
118 RHONCHI 3 0.0022
119 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
120 BIOPSY 2 0.0022
121 HAEMORRHOIDS 42 0.0022
122 FACIAL ASYMMETRY 2 0.0021
123 ANIMAL SCRATCH 2 0.0021
124 COLON ADENOMA 2 0.0020
125 IMPETIGO 3 0.0020
126 DYSPEPSIA 197 0.0020
127 DEVICE RELATED SEPSIS 4 0.0020
128 VASCULAR DEVICE INFECTION 9 0.0020
129 SCHIZOPHRENIA 24 0.0020
130 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
131 IMPLANT SITE SWELLING 2 0.0020
132 BODY TEMPERATURE INCREASED 39 0.0019
133 HYPOPERFUSION 2 0.0019
134 NEUROMYOPATHY 2 0.0019
135 OBESITY 29 0.0018
136 CLOSTRIDIUM TEST POSITIVE 4 0.0018
137 OPEN WOUND 2 0.0018
138 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
139 BLOOD FIBRINOGEN DECREASED 2 0.0018
140 OPEN REDUCTION OF FRACTURE 2 0.0017
141 PERIPHERAL EMBOLISM 2 0.0017
142 ACUTE PRERENAL FAILURE 2 0.0017
143 JOINT RANGE OF MOTION DECREASED 23 0.0017
144 FANCONI SYNDROME ACQUIRED 3 0.0017
145 ESCHERICHIA BACTERAEMIA 4 0.0017
146 SCIATICA 27 0.0017
147 MONOCYTE COUNT DECREASED 2 0.0016
148 HYPERPARATHYROIDISM SECONDARY 4 0.0016
149 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
150 BRONCHIAL SECRETION RETENTION 2 0.0016
151 CANCER PAIN 4 0.0016
152 CUSHINGOID 5 0.0016
153 CHOLELITHIASIS 49 0.0015
154 SKIN DISCOMFORT 4 0.0015
155 CARBON DIOXIDE INCREASED 2 0.0015
156 APPLICATION SITE INFLAMMATION 2 0.0014
157 GRANULOMA 5 0.0014
158 INCISIONAL HERNIA 2 0.0014
159 NEUROGENIC BLADDER 3 0.0014
160 NEUROENDOCRINE TUMOUR 2 0.0014
161 CATAPLEXY 2 0.0014
162 GENITAL RASH 2 0.0014
163 HEPATIC STEATOSIS 26 0.0014
164 ACUTE ABDOMEN 2 0.0014
165 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
166 FOOT DEFORMITY 15 0.0014
167 HEPATOTOXICITY 30 0.0013
168 PITUITARY TUMOUR 2 0.0013
169 METABOLIC ENCEPHALOPATHY 4 0.0013
170 SYNOVITIS 24 0.0013
171 PEMPHIGOID 10 0.0013
172 REBOUND ACID HYPERSECRETION 4 0.0013
173 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
174 MEAN CELL VOLUME DECREASED 2 0.0013
175 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
176 OSTEOSCLEROSIS 2 0.0013
177 RALES 7 0.0012
178 KNEE ARTHROPLASTY 25 0.0012
179 EXPOSURE TO SARS-COV-2 2 0.0012
180 PAPILLARY THYROID CANCER 2 0.0011
181 BRONCHIOLITIS 4 0.0011
182 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
183 BREAST SWELLING 3 0.0011
184 EAR CONGESTION 3 0.0011
185 MONOPARESIS 2 0.0011
186 ESSENTIAL HYPERTENSION 2 0.0011
187 FEBRILE NEUTROPENIA 72 0.0011
188 NEPHROGENIC ANAEMIA 5 0.0011
189 BLOOD BILIRUBIN INCREASED 29 0.0011
190 LUNG CONSOLIDATION 3 0.0011
191 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
192 MECHANICAL VENTILATION 2 0.0011
193 PNEUMATOSIS INTESTINALIS 3 0.0011
194 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
195 LIMB INJURY 28 0.0010
196 HYPOALBUMINAEMIA 8 0.0010
197 OCCULT BLOOD POSITIVE 2 0.0010
198 BACTERAEMIA 12 0.0010
199 HYPERNATRAEMIA 5 0.0010
200 MUCOSAL DRYNESS 2 0.0010
201 JOINT STIFFNESS 26 0.0010
202 ANAEMIA 189 0.0010
203 FUNGAL SKIN INFECTION 4 0.0010
204 ARTHROPATHY 55 0.0010
205 RECTAL CANCER 3 0.0010
206 PERIPHERAL VASCULAR DISORDER 5 0.0010
207 HYPERPARATHYROIDISM 2 0.0010
208 FAILURE TO THRIVE 5 0.0010
209 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
210 MICROCYTIC ANAEMIA 2 0.0010
211 PNEUMONIA ASPIRATION 24 0.0010
212 LIVEDO RETICULARIS 2 0.0010
213 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
214 SKIN EROSION 3 0.0009
215 HYPERPHOSPHATAEMIA 2 0.0009
216 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
217 DYSSTASIA 27 0.0009
218 PERIODONTITIS 2 0.0009
219 ONYCHOMYCOSIS 4 0.0009
220 HAEMORRHAGIC ANAEMIA 4 0.0009
221 MIDDLE EAR EFFUSION 2 0.0009
222 CONGENITAL ANOMALY 7 0.0009
223 FAECES PALE 2 0.0009
224 CONSTIPATION 196 0.0009
225 NEPHRITIS 3 0.0009
226 PYREXIA 308 0.0009
227 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
228 BLOOD LOSS ANAEMIA 2 0.0009
229 METASTASES TO MENINGES 2 0.0009
230 PUSTULAR PSORIASIS 3 0.0009
231 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
232 WEIGHT DECREASED 240 0.0009
233 ARTERIOSCLEROSIS 8 0.0008
234 ERYTHEMA 171 0.0008
235 LYMPHADENITIS 2 0.0008
236 FOETAL GROWTH RESTRICTION 5 0.0008
237 HEPATIC ENZYME INCREASED 56 0.0008
238 PSEUDOMONAS INFECTION 7 0.0008
239 ABDOMINAL PAIN 189 0.0008
240 MOVEMENT DISORDER 26 0.0008
241 HYPERVOLAEMIA 4 0.0008
242 DEVICE INFUSION ISSUE 2 0.0008
243 PARANASAL SINUS DISCOMFORT 3 0.0008
244 INCREASED BRONCHIAL SECRETION 2 0.0008
245 PSYCHOTIC DISORDER 23 0.0008
246 CACHEXIA 4 0.0008
247 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
248 WOUND SECRETION 3 0.0008
249 LUNG OPACITY 2 0.0008
250 CEREBRAL ATROPHY 3 0.0008
251 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
252 PROTEIN TOTAL INCREASED 2 0.0008
253 AZOTAEMIA 3 0.0008
254 BLOOD SODIUM INCREASED 2 0.0007
255 ABDOMINAL RIGIDITY 2 0.0007
256 BONE DENSITY DECREASED 23 0.0007
257 CLONUS 2 0.0007
258 DRUG SCREEN FALSE POSITIVE 2 0.0007
259 MACULE 2 0.0007
260 SKIN DISORDER 24 0.0007
261 MALNUTRITION 8 0.0007
262 ANAL HAEMORRHAGE 2 0.0007
263 OSTEOPOROSIS 29 0.0007
264 OXYGEN SATURATION ABNORMAL 2 0.0007
265 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
266 DUODENAL ULCER HAEMORRHAGE 2 0.0007
267 LIP PAIN 2 0.0007
268 SKIN ATROPHY 4 0.0007
269 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
270 PSORIATIC ARTHROPATHY 28 0.0007
271 ADENOVIRUS INFECTION 2 0.0007
272 HAEMOTHORAX 2 0.0007
273 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
274 OSTEOARTHRITIS 29 0.0007
275 HYPOVOLAEMIA 4 0.0007
276 PARONYCHIA 3 0.0007
277 GINGIVAL SWELLING 3 0.0007
278 LYMPHOCYTE COUNT DECREASED 12 0.0007
279 DECREASED INTEREST 4 0.0007
280 DRUG ERUPTION 12 0.0007
281 MYELOFIBROSIS 2 0.0007
282 EMBOLISM VENOUS 2 0.0007
283 CHEST X-RAY ABNORMAL 2 0.0007
284 EYE OPERATION 3 0.0007
285 BLOOD BLISTER 2 0.0006
286 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
287 BLOOD CREATININE DECREASED 2 0.0006
288 ABDOMINAL ADHESIONS 2 0.0006
289 BLADDER PAIN 2 0.0006
290 POLYMYALGIA RHEUMATICA 2 0.0006
291 HYPOXIA 22 0.0006
292 HUMERUS FRACTURE 3 0.0006
293 RASH VESICULAR 3 0.0006
294 DERMATITIS 13 0.0006
295 BACTERIAL SEPSIS 2 0.0006
296 HYPOVENTILATION 2 0.0006
297 HEPATIC NEOPLASM 2 0.0006
298 OEDEMA MOUTH 2 0.0006
299 OTITIS MEDIA 2 0.0006
300 CORONAVIRUS INFECTION 4 0.0006
301 END STAGE RENAL DISEASE 11 0.0006
302 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
303 EOSINOPHIL COUNT INCREASED 5 0.0006
304 PROSTATE CANCER METASTATIC 2 0.0006
305 CYTOKINE RELEASE SYNDROME 12 0.0006
306 CEREBRAL HAEMATOMA 2 0.0006
307 METASTASES TO SPINE 2 0.0006
308 MALAISE 261 0.0006
309 HEPATIC CYST 2 0.0006
310 LUNG NEOPLASM MALIGNANT 24 0.0006
311 LEFT VENTRICULAR FAILURE 2 0.0006
312 RESPIRATORY DISTRESS 16 0.0006
313 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 30 0.0006
314 AORTIC STENOSIS 2 0.0006
315 PAPULE 4 0.0006
316 INCONTINENCE 6 0.0006
317 FACIAL PARESIS 2 0.0006
318 ANORECTAL DISCOMFORT 3 0.0006
319 LIVER DISORDER 25 0.0006
320 FIBRIN D DIMER INCREASED 2 0.0006
321 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
322 ANAL FISSURE 3 0.0006
323 ANAL ABSCESS 3 0.0006
324 HAEMATOCRIT DECREASED 11 0.0006
325 HYDROCEPHALUS 3 0.0006
326 FAECALOMA 3 0.0005
327 HYPOPHOSPHATAEMIA 4 0.0005
328 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
329 ARTHROPOD BITE 4 0.0005
330 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
331 STREPTOCOCCAL INFECTION 3 0.0005
332 ORAL PAIN 12 0.0005
333 MUSCULOSKELETAL PAIN 28 0.0005
334 CATHETER SITE INFECTION 2 0.0005
335 GASTRIC INFECTION 2 0.0005
336 BOWEL MOVEMENT IRREGULARITY 4 0.0005
337 HERPES VIRUS INFECTION 3 0.0005
338 RENAL FAILURE CHRONIC 4 0.0005
339 DEVICE RELATED INFECTION 8 0.0005
340 HYPERCHOLESTEROLAEMIA 5 0.0005
341 ATELECTASIS 5 0.0005
342 FAECES HARD 2 0.0005
343 THERAPY PARTIAL RESPONDER 8 0.0005
344 PULMONARY HAEMORRHAGE 4 0.0005
345 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
346 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
347 WHEEZING 30 0.0005
348 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
349 MYASTHENIA GRAVIS 4 0.0005
350 INGUINAL HERNIA 3 0.0005
351 DERMATITIS ACNEIFORM 3 0.0005
352 PERIPHERAL VENOUS DISEASE 2 0.0005
353 HYPERURICAEMIA 2 0.0005
354 SPINAL COMPRESSION FRACTURE 4 0.0005
355 TRANSFUSION 5 0.0005
356 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
357 CANDIDA INFECTION 8 0.0005
358 FEBRILE BONE MARROW APLASIA 2 0.0005
359 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
360 PURULENT DISCHARGE 2 0.0005
361 METASTATIC NEOPLASM 2 0.0005
362 NEUTROPENIA 63 0.0005
363 HYSTERECTOMY 4 0.0005
364 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
365 CHAPPED LIPS 2 0.0005
366 PAIN 282 0.0005
367 MUCOSAL INFLAMMATION 12 0.0005
368 BEDRIDDEN 6 0.0005
369 DYSPHEMIA 2 0.0005
370 PULMONARY CONGESTION 6 0.0005
371 GASTROINTESTINAL PAIN 5 0.0005
372 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
373 ABDOMINAL ABSCESS 2 0.0005
374 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
375 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
376 DIABETES MELLITUS 34 0.0004
377 SKIN INFECTION 5 0.0004
378 METASTASES TO LYMPH NODES 3 0.0004
379 MITRAL VALVE INCOMPETENCE 5 0.0004
380 TACHYPNOEA 6 0.0004
381 DERMATITIS CONTACT 5 0.0004
382 SCAB 5 0.0004
383 DROOLING 3 0.0004
384 INTENTIONAL PRODUCT MISUSE 38 0.0004
385 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
386 CONJUNCTIVITIS 8 0.0004
387 ARTHRITIS INFECTIVE 2 0.0004
388 HYPOPHAGIA 11 0.0004
389 ERYTHEMA MULTIFORME 4 0.0004
390 DEFORMITY 4 0.0004
391 METASTASES TO BONE 7 0.0004
392 STAPHYLOCOCCAL INFECTION 14 0.0004
393 PULMONARY TOXICITY 3 0.0004
394 COVID-19 PNEUMONIA 5 0.0004
395 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
396 DIVERTICULUM 3 0.0004
397 BLOOD URINE PRESENT 8 0.0004
398 SEPSIS 47 0.0004
399 PROTEINURIA 8 0.0004
400 SUBDURAL HAEMATOMA 6 0.0004
401 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
402 HYPERLIPIDAEMIA 5 0.0004
403 CELLULITIS 21 0.0004
404 GASTROINTESTINAL TOXICITY 2 0.0004
405 DERMATITIS BULLOUS 3 0.0004
406 SEPTIC SHOCK 18 0.0004
407 FAECES SOFT 3 0.0004
408 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
409 CARDIOMYOPATHY 6 0.0004
410 OEDEMA 22 0.0004
411 MUCOUS STOOLS 2 0.0004
412 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
413 DELIRIUM 14 0.0004
414 TOOTH EXTRACTION 5 0.0004
415 HYDRONEPHROSIS 3 0.0004
416 HYPERAMMONAEMIA 2 0.0004
417 ERYSIPELAS 2 0.0004
418 DRUG INEFFECTIVE 523 0.0004
419 MENTAL STATUS CHANGES 11 0.0004
420 PRODUCT ADMINISTRATION ERROR 8 0.0004
421 HYPOTHERMIA 4 0.0004
422 CHILLS 46 0.0004
423 SLUGGISHNESS 4 0.0004
424 CEREBRAL ISCHAEMIA 2 0.0004
425 OFF LABEL USE 339 0.0004
426 SKIN ULCER 10 0.0004
427 POOR VENOUS ACCESS 4 0.0004
428 HIATUS HERNIA 5 0.0004
429 HAEMORRHAGIC STROKE 3 0.0004
430 RESPIRATORY FAILURE 28 0.0004
431 HERPES ZOSTER 22 0.0004
432 AFFECTIVE DISORDER 3 0.0004
433 ARTHRITIS 30 0.0004
434 FURUNCLE 3 0.0004
435 BLOOD ALBUMIN DECREASED 3 0.0004
436 RENAL PAIN 4 0.0004
437 GINGIVAL PAIN 3 0.0004
438 ANAL FISTULA 2 0.0004
439 TRANSPLANT REJECTION 3 0.0004
440 BACK PAIN 87 0.0004
441 NAUSEA 296 0.0004
442 URINARY INCONTINENCE 11 0.0004
443 GINGIVITIS 2 0.0004
444 MUSCLE DISORDER 3 0.0004
445 FIBROMYALGIA 9 0.0004
446 BLOOD POTASSIUM INCREASED 6 0.0004
447 NORMAL NEWBORN 2 0.0004
448 SKIN LACERATION 4 0.0004
449 INTESTINAL ISCHAEMIA 2 0.0004
450 HYPERKERATOSIS 2 0.0004
451 CYSTIC FIBROSIS 2 0.0004
452 OEDEMA PERIPHERAL 44 0.0004
453 DRUG ABUSE 30 0.0004
454 BLOOD UREA INCREASED 6 0.0004
455 SKIN FISSURES 7 0.0004
456 BLOOD TEST ABNORMAL 5 0.0004
457 MUSCULOSKELETAL STIFFNESS 31 0.0004
458 BLOOD CREATININE INCREASED 23 0.0004
459 INTERNAL HAEMORRHAGE 4 0.0003
460 HYPERTONIA 2 0.0003
461 LETHARGY 20 0.0003
462 HYPOKALAEMIA 16 0.0003
463 BLOOD URIC ACID INCREASED 2 0.0003
464 TASTE DISORDER 7 0.0003
465 CHRONIC KIDNEY DISEASE 26 0.0003
466 BLOOD IRON DECREASED 4 0.0003
467 CATARACT OPERATION 2 0.0003
468 ANAL INCONTINENCE 3 0.0003
469 LEUKOCYTOSIS 6 0.0003
470 OSTEOMYELITIS 6 0.0003
471 PNEUMONITIS 9 0.0003
472 HEADACHE 206 0.0003
473 CEREBRAL INFARCTION 8 0.0003
474 MUSCLE SPASTICITY 4 0.0003
475 IRON DEFICIENCY ANAEMIA 3 0.0003
476 HYPERCALCAEMIA 4 0.0003
477 PHARYNGITIS 4 0.0003
478 OLIGURIA 2 0.0003
479 DEMENTIA 9 0.0003
480 INFUSION SITE SWELLING 2 0.0003
481 BLEPHAROSPASM 2 0.0003
482 SPINAL DISORDER 3 0.0003
483 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
484 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
485 PULMONARY OEDEMA 14 0.0003
486 PLEURAL EFFUSION 19 0.0003
487 ACUTE RESPIRATORY FAILURE 6 0.0003
488 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
489 SINUS BRADYCARDIA 3 0.0003
490 ANAPHYLACTIC SHOCK 8 0.0003
491 DIZZINESS POSTURAL 3 0.0003
492 RENAL FAILURE 41 0.0003
493 THROMBOTIC MICROANGIOPATHY 3 0.0003
494 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
495 DEAFNESS 8 0.0003
496 RENAL TUBULAR NECROSIS 3 0.0003
497 PNEUMONIA 99 0.0003
498 ECZEMA 16 0.0003
499 IMPAIRED HEALING 10 0.0003
500 HOSPICE CARE 3 0.0003
501 LIGAMENT SPRAIN 3 0.0003
502 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
503 HYPONATRAEMIA 17 0.0003
504 URINARY RETENTION 10 0.0003
505 DYSURIA 11 0.0003
506 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
507 TOXIC SKIN ERUPTION 3 0.0003
508 PAIN OF SKIN 8 0.0003
509 BONE MARROW FAILURE 6 0.0003
510 HEPATIC FUNCTION ABNORMAL 11 0.0003
511 RASH ERYTHEMATOUS 14 0.0003
512 BLOOD TESTOSTERONE DECREASED 2 0.0003
513 INFARCTION 2 0.0003
514 EYE MOVEMENT DISORDER 2 0.0003
515 HAEMATURIA 10 0.0003
516 LYMPHOEDEMA 2 0.0003
517 EYE DISCHARGE 3 0.0003
518 HYPOMAGNESAEMIA 4 0.0003
519 ORTHOSTATIC HYPOTENSION 5 0.0003
520 HAEMOPTYSIS 8 0.0003
521 MASS 4 0.0003
522 HYPERKALAEMIA 10 0.0003
523 OXYGEN SATURATION DECREASED 16 0.0003
524 FULL BLOOD COUNT ABNORMAL 3 0.0003
525 LYMPHADENOPATHY 10 0.0003
526 HEAD DISCOMFORT 5 0.0003
527 GAIT DISTURBANCE 54 0.0003
528 EATING DISORDER 6 0.0003
529 SINUS TACHYCARDIA 4 0.0003
530 RETCHING 6 0.0003
531 JOINT INJURY 6 0.0003
532 IMPAIRED QUALITY OF LIFE 4 0.0003
533 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
534 GASTROENTERITIS 4 0.0003
535 ASPIRATION 3 0.0003
536 DENTAL CARIES 3 0.0003
537 VIRAL INFECTION 9 0.0003
538 VENTRICULAR FIBRILLATION 3 0.0003
539 FUNGAL INFECTION 9 0.0003
540 BACTERIAL INFECTION 5 0.0003
541 STATUS EPILEPTICUS 3 0.0003
542 BREAST TENDERNESS 2 0.0003
543 FLATULENCE 15 0.0003
544 HYPERTENSION 56 0.0003
545 HYPOCALCAEMIA 5 0.0003
546 VOMITING 124 0.0003
547 MYOCARDIAL ISCHAEMIA 3 0.0003
548 OSTEOPENIA 4 0.0003
549 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
550 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
551 SLEEP APNOEA SYNDROME 5 0.0003
552 ACUTE KIDNEY INJURY 40 0.0003
553 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
554 SEROTONIN SYNDROME 5 0.0003
555 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
556 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
557 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
558 ELECTROLYTE IMBALANCE 3 0.0003
559 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
560 URINARY TRACT INFECTION 44 0.0003
561 APHTHOUS ULCER 2 0.0003
562 EAR PAIN 5 0.0003
563 ABDOMINAL DISCOMFORT 43 0.0003
564 SPINAL PAIN 3 0.0003
565 DIARRHOEA 165 0.0003
566 PRODUCT USE COMPLAINT 4 0.0003
567 PSORIASIS 33 0.0003
568 PNEUMOTHORAX 4 0.0003
569 SEIZURE 29 0.0003
570 MUSCLE RIGIDITY 3 0.0003
571 ABSCESS 4 0.0003
572 PRESCRIBED UNDERDOSE 5 0.0003
573 PANCYTOPENIA 14 0.0003
574 BLOOD DISORDER 2 0.0002
575 RHINORRHOEA 16 0.0002
576 ADRENAL INSUFFICIENCY 3 0.0002
577 NEUTROPHIL COUNT DECREASED 10 0.0002
578 ENCEPHALOPATHY 6 0.0002
579 HYPERSOMNIA 7 0.0002
580 ABNORMAL FAECES 2 0.0002
581 CARDIOMEGALY 3 0.0002
582 OSTEONECROSIS OF JAW 6 0.0002
583 EYE SWELLING 9 0.0002
584 HEMIPLEGIA 2 0.0002
585 COAGULOPATHY 4 0.0002
586 OROPHARYNGEAL PAIN 22 0.0002
587 BRAIN OEDEMA 3 0.0002
588 MUSCLE ATROPHY 3 0.0002
589 RESPIRATORY DISORDER 7 0.0002
590 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
591 ANURIA 2 0.0002
592 HAEMATOMA 6 0.0002
593 MYOPATHY 2 0.0002
594 PRURITUS GENERALISED 5 0.0002
595 MUSCLE STRAIN 2 0.0002
596 STOMATITIS 14 0.0002
597 DEEP VEIN THROMBOSIS 15 0.0002
598 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
599 FAECES DISCOLOURED 5 0.0002
600 AMENORRHOEA 4 0.0002
601 BLOOD CALCIUM INCREASED 2 0.0002
602 IMMUNE SYSTEM DISORDER 3 0.0002
603 TOOTH INFECTION 3 0.0002
604 PRODUCT COMMUNICATION ISSUE 2 0.0002
605 LUNG INFILTRATION 2 0.0002
606 HAEMOGLOBIN DECREASED 23 0.0002
607 CONDITION AGGRAVATED 68 0.0002
608 THROMBOCYTOPENIA 25 0.0002
609 HAEMOLYTIC ANAEMIA 2 0.0002
610 GASTROINTESTINAL INFECTION 2 0.0002
611 C-REACTIVE PROTEIN INCREASED 8 0.0002
612 CYSTITIS 7 0.0002
613 BONE DISORDER 4 0.0002
614 EXOSTOSIS 2 0.0002
615 SKIN LESION 6 0.0002
616 ASTHENIA 82 0.0002
617 PNEUMONIA BACTERIAL 2 0.0002
618 DIVERTICULITIS 6 0.0002
619 BRONCHITIS 16 0.0002
620 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
621 FEELING COLD 6 0.0002
622 INFLUENZA 24 0.0002
623 HEPATIC ENCEPHALOPATHY 2 0.0002
624 APPENDICITIS 2 0.0002
625 BURNING SENSATION 15 0.0002
626 FLANK PAIN 2 0.0002
627 CARDIAC FAILURE CONGESTIVE 17 0.0002
628 DEHYDRATION 28 0.0002
629 CARDIOGENIC SHOCK 3 0.0002
630 HERNIA 4 0.0002
631 HYPOKINESIA 3 0.0002
632 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
633 NEURALGIA 5 0.0002
634 ATRIAL FIBRILLATION 20 0.0002
635 AUTOIMMUNE DISORDER 2 0.0002
636 PARKINSONISM 2 0.0002
637 CHOKING 4 0.0002
638 RASH 89 0.0002
639 LUNG DISORDER 10 0.0002
640 KIDNEY INFECTION 4 0.0002
641 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
642 SKIN HAEMORRHAGE 3 0.0002
643 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
644 RENAL INJURY 6 0.0002
645 SINUS DISORDER 4 0.0002
646 BLADDER DISORDER 2 0.0002
647 PULMONARY MASS 3 0.0002
648 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
649 FALL 67 0.0002
650 BLOOD PRESSURE ABNORMAL 4 0.0002
651 HAEMORRHAGE INTRACRANIAL 3 0.0002
652 HYPOAESTHESIA ORAL 3 0.0002
653 EMPHYSEMA 2 0.0002
654 HAEMATEMESIS 5 0.0002
655 PRODUCT DOSE OMISSION ISSUE 58 0.0002
656 DEVICE FAILURE 3 0.0002
657 EYELID PTOSIS 2 0.0002
658 NEUTROPHIL COUNT INCREASED 2 0.0002
659 ERECTILE DYSFUNCTION 5 0.0002
660 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
661 FEMUR FRACTURE 6 0.0002
662 PERITONITIS 4 0.0002
663 HYPERBILIRUBINAEMIA 2 0.0002
664 DIPLOPIA 5 0.0002
665 ACUTE MYELOID LEUKAEMIA 3 0.0002
666 PULMONARY HYPERTENSION 4 0.0002
667 RESPIRATORY TRACT INFECTION 5 0.0002
668 SEDATION 5 0.0002
669 MOUTH ULCERATION 4 0.0002
670 ULCER 3 0.0002
671 BONE PAIN 11 0.0002
672 EPISTAXIS 14 0.0002
673 HIP FRACTURE 6 0.0002
674 DYSPNOEA EXERTIONAL 7 0.0002
675 PHARYNGITIS STREPTOCOCCAL 2 0.0002
676 HYPOTENSION 37 0.0002
677 PALLOR 5 0.0002
678 CHEST PAIN 34 0.0002
679 OESOPHAGITIS 2 0.0002
680 MELAENA 4 0.0002
681 APPLICATION SITE PAIN 4 0.0002
682 DRUG LEVEL INCREASED 3 0.0002
683 CYTOMEGALOVIRUS INFECTION 3 0.0002
684 STEVENS-JOHNSON SYNDROME 4 0.0002
685 MEDICATION ERROR 10 0.0002
686 WOUND 5 0.0002
687 RENAL IMPAIRMENT 15 0.0002
688 SNEEZING 4 0.0002
689 SKIN EXFOLIATION 15 0.0002
690 DECREASED APPETITE 41 0.0002
691 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
692 NEOPLASM 2 0.0002
693 SHOCK 4 0.0002
694 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
695 MULTI-ORGAN FAILURE 3 0.0002
696 METASTASES TO LUNG 2 0.0002
697 PERICARDIAL EFFUSION 4 0.0002
698 EYELID OEDEMA 2 0.0002
699 BLOOD CHOLESTEROL INCREASED 8 0.0002
700 ASCITES 5 0.0002
701 ACUTE MYOCARDIAL INFARCTION 5 0.0002
702 PLATELET COUNT DECREASED 18 0.0002
703 DRUG DEPENDENCE 27 0.0002
704 CHOLECYSTITIS 2 0.0002
705 POLLAKIURIA 7 0.0002
706 BLOOD PRESSURE FLUCTUATION 4 0.0002
707 INFECTION 24 0.0002
708 TOOTHACHE 3 0.0002
709 RENAL FAILURE ACUTE 7 0.0002
710 HYPOGLYCAEMIA 8 0.0002
711 BURSITIS 2 0.0002
712 NEOPLASM MALIGNANT 11 0.0002
713 NOCTURIA 2 0.0002
714 PANIC ATTACK 6 0.0002
715 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
716 DISCOMFORT 10 0.0002
717 EPILEPSY 5 0.0002
718 ARTHRALGIA 68 0.0002
719 CYTOPENIA 2 0.0002
720 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
721 OVERDOSE 35 0.0002
722 CARDIAC FAILURE 13 0.0002
723 GENERALISED OEDEMA 2 0.0002
724 ILEUS 2 0.0002
725 BLISTER 9 0.0002
726 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
727 COVID-19 28 0.0002
728 DYSARTHRIA 6 0.0002
729 PULMONARY EMBOLISM 15 0.0002
730 TACHYCARDIA 14 0.0002
731 METABOLIC ACIDOSIS 5 0.0002
732 THERAPY NON-RESPONDER 7 0.0002
733 NIGHT SWEATS 5 0.0002
734 LACTIC ACIDOSIS 5 0.0002
735 ORAL HERPES 3 0.0002
736 ABDOMINAL DISTENSION 16 0.0002
737 SPEECH DISORDER 8 0.0002
738 NEPHROLITHIASIS 7 0.0002
739 SPINAL FRACTURE 3 0.0001
740 HAIR TEXTURE ABNORMAL 2 0.0001
741 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
742 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
743 FLUSHING 15 0.0001
744 DYSPHAGIA 14 0.0001
745 IMPAIRED GASTRIC EMPTYING 2 0.0001
746 SINUSITIS 15 0.0001
747 RIB FRACTURE 3 0.0001
748 PERIPHERAL COLDNESS 2 0.0001
749 INTERSTITIAL LUNG DISEASE 7 0.0001
750 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
751 SOMNOLENCE 29 0.0001
752 ORAL DISCOMFORT 2 0.0001
753 CONFUSIONAL STATE 23 0.0001
754 DEVICE OCCLUSION 2 0.0001
755 HALLUCINATION, VISUAL 3 0.0001
756 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
757 PAIN IN JAW 4 0.0001
758 DIALYSIS 2 0.0001
759 MUSCULAR WEAKNESS 16 0.0001
760 LOSS OF CONSCIOUSNESS 18 0.0001
761 DRY EYE 7 0.0001
762 BRONCHOSPASM 2 0.0001
763 LIVER FUNCTION TEST INCREASED 3 0.0001
764 PARALYSIS 2 0.0001
765 ANGINA PECTORIS 4 0.0001
766 PRODUCT USE ISSUE 26 0.0001
767 PRODUCT PRESCRIBING ISSUE 3 0.0001
768 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
769 HYPERGLYCAEMIA 5 0.0001
770 ACCIDENTAL OVERDOSE 5 0.0001
771 INFLAMMATION 7 0.0001
772 ANGIOEDEMA 6 0.0001
773 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
774 INJECTION SITE MASS 5 0.0001
775 IMMUNODEFICIENCY 2 0.0001
776 BLOOD POTASSIUM DECREASED 4 0.0001
777 HEART RATE IRREGULAR 3 0.0001
778 HEPATIC FAILURE 4 0.0001
779 INTESTINAL OBSTRUCTION 5 0.0001
780 APHASIA 4 0.0001
781 ILL-DEFINED DISORDER 8 0.0001
782 SKIN IRRITATION 6 0.0001
783 HIP ARTHROPLASTY 2 0.0001
784 FEELING HOT 8 0.0001
785 PHARYNGEAL OEDEMA 2 0.0001
786 MUSCULOSKELETAL CHEST PAIN 2 0.0001
787 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
788 RENAL DISORDER 6 0.0001
789 DELUSION 2 0.0001
790 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
791 NERVOUS SYSTEM DISORDER 4 0.0001
792 CYANOSIS 2 0.0001
793 DISEASE PROGRESSION 15 0.0001
794 DISORIENTATION 5 0.0001
795 DISEASE RECURRENCE 6 0.0001
796 COMA 6 0.0001
797 PRODUCT PRESCRIBING ERROR 3 0.0001
798 NECK PAIN 7 0.0001
799 PRURITUS 48 0.0001
800 BLOOD PRESSURE INCREASED 19 0.0001
801 LOCALISED INFECTION 3 0.0001
802 LIVER INJURY 3 0.0001
803 EYE IRRITATION 7 0.0001
804 AGEUSIA 3 0.0001
805 SYNCOPE 12 0.0001
806 ROAD TRAFFIC ACCIDENT 5 0.0001
807 HOT FLUSH 9 0.0001
808 PAIN IN EXTREMITY 35 0.0001
809 FLUID RETENTION 6 0.0001
810 COUGH 33 0.0001
811 MYALGIA 20 0.0001
812 SWELLING 11 0.0001
813 CIRCULATORY COLLAPSE 2 0.0001
814 HOSPITALISATION 18 0.0001
815 PERIPHERAL SWELLING 18 0.0001
816 DYSPNOEA 66 0.0001
817 HYPERHIDROSIS 15 0.0001
818 UNRESPONSIVE TO STIMULI 3 0.0001
819 MUSCULOSKELETAL DISCOMFORT 2 0.0001
820 NEUROTOXICITY 2 0.0001
821 NASOPHARYNGITIS 21 0.0001
822 HEART RATE DECREASED 4 0.0001
823 SLEEP DISORDER 8 0.0001
824 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
825 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
826 EAR INFECTION 3 0.0001
827 FATIGUE 87 0.0001
828 CEREBRAL HAEMORRHAGE 4 0.0001
829 MOBILITY DECREASED 8 0.0001
830 MYELOSUPPRESSION 4 0.0001
831 GASTROENTERITIS VIRAL 2 0.0001
832 UNDERDOSE 8 0.0001
833 MUSCLE SPASMS 20 0.0001
834 AGRANULOCYTOSIS 2 0.0001
835 SWELLING FACE 7 0.0001
836 CHEST DISCOMFORT 11 0.0001
837 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
838 MIDDLE INSOMNIA 2 0.0001
839 ALOPECIA 21 0.0001
840 ILLNESS 11 0.0001
841 EYE PAIN 6 0.0001
842 BLOOD SODIUM DECREASED 2 0.0001
843 BLOOD PRESSURE DECREASED 7 0.0001
844 HAEMORRHAGE 11 0.0001
845 MUSCULOSKELETAL DISORDER 2 0.0001
846 RED BLOOD CELL COUNT DECREASED 3 0.0001
847 VISUAL IMPAIRMENT 13 0.0001
848 MIGRAINE 10 0.0001
849 BALANCE DISORDER 9 0.0001
850 CONTUSION 10 0.0001
851 GLAUCOMA 2 0.0001
852 ERUCTATION 2 0.0001
853 LIVER FUNCTION TEST ABNORMAL 3 0.0001
854 DYSTONIA 2 0.0001
855 NEEDLE ISSUE 3 0.0001
856 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
857 HYPERSENSITIVITY 19 0.0001
858 SURGERY 6 0.0001
859 MEMORY IMPAIRMENT 14 0.0001
860 LABORATORY TEST ABNORMAL 3 0.0001
861 INSOMNIA 27 0.0001
862 GASTROINTESTINAL DISORDER 9 0.0001
863 FULL BLOOD COUNT DECREASED 2 0.0001
864 CORONARY ARTERY DISEASE 3 0.0001
865 DRY MOUTH 8 0.0001
866 DYSKINESIA 4 0.0001
867 PRODUCT PREPARATION ERROR 2 0.0001
868 CARDIAC ARREST 8 0.0001
869 CARDIAC DISORDER 9 0.0001
870 CARDIO-RESPIRATORY ARREST 4 0.0001
871 DRUG-INDUCED LIVER INJURY 3 0.0001
872 PARAESTHESIA 15 0.0001
873 WITHDRAWAL SYNDROME 4 0.0001
874 BRADYCARDIA 5 0.0001
875 HYPOTHYROIDISM 3 0.0001
876 DRUG INTOLERANCE 9 0.0001
877 HYPOACUSIS 4 0.0001
878 POOR QUALITY SLEEP 2 0.0001
879 HALLUCINATION 7 0.0001
880 DEPRESSION 21 0.0001
881 ABDOMINAL PAIN UPPER 19 0.0001
882 DEVICE LEAKAGE 4 0.0001
883 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
884 HEART RATE INCREASED 9 0.0001
885 EXPIRED PRODUCT ADMINISTERED 3 0.0001
886 LIP SWELLING 3 0.0001
887 PANCREATITIS ACUTE 2 0.0001
888 ASTHMA 10 0.0001
889 PRODUCT AVAILABILITY ISSUE 2 0.0001
890 FEELING ABNORMAL 21 0.0001
891 CONVULSION 5 0.0001
892 MUSCLE TWITCHING 2 0.0001
893 NEOPLASM PROGRESSION 3 0.0001
894 ARRHYTHMIA 4 0.0001
895 TREMOR 14 0.0001
896 THERAPY INTERRUPTED 6 0.0001
897 PRODUCTIVE COUGH 4 0.0001
898 URTICARIA 14 0.0001
899 BLOOD GLUCOSE DECREASED 4 0.0001
900 DIABETIC KETOACIDOSIS 2 0.0001
901 DRUG EFFECT INCOMPLETE 3 0.0001
902 THERAPEUTIC RESPONSE DECREASED 5 0.0001
903 DIZZINESS 41 0.0001
904 DRUG INTERACTION 13 0.0001
905 AGITATION 6 0.0001
906 DYSGEUSIA 6 0.0001
907 LEUKOPENIA 4 0.0001
908 ACNE 6 0.0001
909 GASTRIC CANCER 2 0.0001
910 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
911 APPLICATION SITE ERYTHEMA 2 0.0001
912 DERMATITIS ATOPIC 4 0.0001
913 DRY SKIN 10 0.0001
914 MYOCARDIAL INFARCTION 13 0.0001
915 JAUNDICE 2 0.0001
916 BLOOD GLUCOSE INCREASED 14 0.0001
917 DISTURBANCE IN ATTENTION 4 0.0001
918 RASH PRURITIC 4 0.0001
919 ANXIETY 21 0.0001
920 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
921 VISION BLURRED 10 0.0001
922 TREATMENT FAILURE 6 0.0001
923 ANAPHYLACTIC REACTION 4 0.0001
924 RHABDOMYOLYSIS 3 0.0001
925 DEVICE DISLOCATION 3 0.0001
926 MENTAL DISORDER 3 0.0001
927 DYSPHONIA 4 0.0001
928 NASAL CONGESTION 4 0.0001
929 CATARACT 4 0.0001
930 THROAT IRRITATION 3 0.0001
931 IRRITABILITY 4 0.0001
932 PREMATURE BABY 2 0.0001
933 LACRIMATION INCREASED 2 0.0001
934 EMOTIONAL DISTRESS 8 0.0001
935 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
936 VERTIGO 4 0.0001
937 SKIN DISCOLOURATION 3 0.0001
938 DRUG ADMINISTRATION ERROR 2 0.0001
939 LIMB DISCOMFORT 2 0.0001
940 COGNITIVE DISORDER 3 0.0001
941 OCULAR HYPERAEMIA 3 0.0001
942 NEUROPATHY PERIPHERAL 6 0.0001
943 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
944 GAIT INABILITY 2 0.0001
945 EYE PRURITUS 2 0.0001
946 TOXICITY TO VARIOUS AGENTS 10 0.0001
947 GASTRIC DISORDER 2 0.0001
948 INJECTION SITE REACTION 4 0.0001
949 WEIGHT INCREASED 13 0.0001
950 NIGHTMARE 2 0.0001
951 DEVICE USE ERROR 2 0.0001
952 NERVOUSNESS 3 0.0001
953 DEATH 49 0.0001
954 SKIN BURNING SENSATION 4 0.0001
955 RHEUMATOID ARTHRITIS 6 0.0001
956 PLASMA CELL MYELOMA 2 0.0001
957 PALPITATIONS 6 0.0001
958 ABNORMAL BEHAVIOUR 2 0.0001
959 THROMBOSIS 4 0.0000
960 JOINT SWELLING 6 0.0000
961 BLINDNESS 2 0.0000
962 EXPOSURE DURING PREGNANCY 3 0.0000
963 HYPOAESTHESIA 7 0.0000
964 INJECTION SITE PAIN 14 0.0000
965 DRUG WITHDRAWAL SYNDROME 4 0.0000
966 DEVICE MALFUNCTION 3 0.0000
967 INJURY 3 0.0000
968 COLORECTAL CANCER 2 0.0000
969 MULTIPLE SCLEROSIS 2 0.0000
970 CEREBROVASCULAR ACCIDENT 7 0.0000
971 AGGRESSION 2 0.0000
972 UNEVALUABLE EVENT 3 0.0000
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
974 PANCREATITIS 2 0.0000
975 DEPRESSED MOOD 2 0.0000
976 INCORRECT DOSE ADMINISTERED 8 0.0000
977 PRODUCT SUBSTITUTION ISSUE 2 0.0000
978 DEVICE ISSUE 3 0.0000
979 ADVERSE EVENT 3 0.0000
980 AMNESIA 2 0.0000
981 PRODUCT DOSE OMISSION 2 0.0000
982 PRODUCT QUALITY ISSUE 4 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
984 INJECTION SITE SWELLING 2 0.0000
985 INJECTION SITE BRUISING 2 0.0000
986 PROSTATE CANCER 2 0.0000
987 INFLUENZA LIKE ILLNESS 2 0.0000
988 DRUG DOSE OMISSION 4 0.0000
989 PRODUCT STORAGE ERROR 2 0.0000
990 ADVERSE DRUG REACTION 2 0.0000
991 BREAST CANCER 2 0.0000
992 NO ADVERSE EVENT 3 0.0000
993 INJECTION SITE ERYTHEMA 2 0.0000